DUBLIN – Polyphor AG is seeking up to CHF140 million (US$141.4 million) in Switzerland's first biotech IPO since November 2014. The IPO comprises a base offering of shares that would bring in CHF100 million plus an "upsize option" that would add CHF40 million more. An overallotment option, if exercised, would add another CHF10 million to the proceeds.